11-36506475-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.-23+3573C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.975 in 152,264 control chromosomes in the GnomAD database, including 72,486 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.98 ( 72486 hom., cov: 31)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.06

Publications

1 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.-23+3573C>A
intron
N/ANP_004611.1
TRAF6
NM_145803.3
c.-116+3573C>A
intron
N/ANP_665802.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.-23+3573C>A
intron
N/AENSP00000433623.1
TRAF6
ENST00000348124.5
TSL:1
c.-116+3573C>A
intron
N/AENSP00000337853.5
TRAF6
ENST00000876418.1
c.-23+3573C>A
intron
N/AENSP00000546477.1

Frequencies

GnomAD3 genomes
AF:
0.975
AC:
148368
AN:
152146
Hom.:
72428
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.918
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.991
Gnomad ASJ
AF:
0.994
Gnomad EAS
AF:
0.997
Gnomad SAS
AF:
0.970
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.980
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.975
AC:
148485
AN:
152264
Hom.:
72486
Cov.:
31
AF XY:
0.976
AC XY:
72695
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.919
AC:
38133
AN:
41512
American (AMR)
AF:
0.991
AC:
15153
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.994
AC:
3449
AN:
3470
East Asian (EAS)
AF:
0.997
AC:
5179
AN:
5192
South Asian (SAS)
AF:
0.970
AC:
4688
AN:
4832
European-Finnish (FIN)
AF:
1.00
AC:
10614
AN:
10614
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67996
AN:
68040
Other (OTH)
AF:
0.980
AC:
2071
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
166
332
497
663
829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.991
Hom.:
104227
Bravo
AF:
0.973
Asia WGS
AF:
0.972
AC:
3380
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.017
DANN
Benign
0.29
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs520074; hg19: chr11-36528025; API